Skip to content

Pathological Mechanism Study of Aerobic Exercise Regulating Cold Stress-induced Hypertension Via the Thermosensitive Target-mediated Sympathetic Nerve Pathway

Pathological Mechanism Study of Aerobic Exercise Regulating Cold Stress-induced Hypertension Via the Thermosensitive Target-mediated Sympathetic Nerve Pathway

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07666607
Enrollment
200
Registered
2026-06-24
Start date
2024-10-04
Completion date
2025-12-28
Last updated
2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

This study focuses on the specificity of thermosensitive targets in populations with hypertension in cold regions, identifies core targets through transcriptome sequencing and clinical validation, and clarifies the regulatory mechanism of moderate-intensity aerobic exercise through a prospective cohort study, providing scientific basis for precise prevention and treatment of hypertension in cold regions and personalized exercise intervention.

Interventions

Patients with essential hypertension in cold regions who met the inclusion criteria were prospectively recruited and divided into an exercise exposure group and a non-exercise control group based on their willingness to accept and adhere to the exercise protocol developed for this study, with a follow-up period of 16 weeks. At baseline and the end of follow-up, we measured the expression of core thermosensitive targets, blood pressure (BP), heart rate variability (HRV), as well as the levels of sympathetic neurotransmitters and indicators of the renin-angiotensin-aldosterone system (RAAS), and compared the changes in these indicators between the two groups.

Sponsors

Wang Jingfeng
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Same as the inclusion criteria for cold region hypertensive patients in the first stage; No regular moderate-intensity aerobic exercise in the past 3 months (≥3 times per week, ≥30 minutes per session); Exercise risk assessment is low to moderate risk (negative PAR-Q+ questionnaire); Voluntarily participate in this study and sign informed consent.

Exclusion criteria

* Same as the

Design outcomes

Primary

MeasureTime frameDescription
blood pressure (BP)December 28, 2025Systolic blood pressure, unit: mmHg Diastolic blood pressure, unit: mmHg Mean arterial pressure, unit: mmHg
heart rate variability (HRV)28 December 2025Low Frequency,Unit: nu High Frequency ,Unit: nu Low Frequency / High Frequency ratio Root Mean Square of Successive Differences,Unit: ms Percentage of successive NN intervals differing by more than 50 ms,Unit: % Standard Deviation of all Normal-to-Normal RR intervals,Unit: ms
markers of the sympathetic nervous system (SNS)December 28, 2025Epinephrine, unit: ng/L Norepinephrine, unit: ng/L
mRNA expression of genesDecember 28, 2025Unit: relative expression level

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 25, 2026